Cite Filings / ROIV / 0000315066-25-002091

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Roivant Sciences Ltd. Filed 2025-08-06 Acc 0000315066-25-002091

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-11 10-Q Quarterly Report
2025-08-07 SCHEDULE 13G Statement of Beneficial Ownership
2025-08-06 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-01 4 President and Vant Chair acquired 13,736,547 shares (grant or award)
2025-08-01 4 President & Immunovant CEO acquired 198,413 shares (grant or award)
2025-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…